logo

NOVA News

We are very happy to announce that the Idylla™ ctEGFR Mutation Assay is launched! This is an exciting update for our lung cancer portfolio!

The fully automated IdyllaTMctEGFR Mutation Assay (RUO), fast and easy to perform, can be used to determine the EGFR mutation status using liquid biopsy plasma samples. IdyllaTMctEGFR covers 49 EGFR mutations in exons 18, 19, 20 & 21 and showed high concordance compared to NGS.

For research use only. Not for use in diagnostic procedures.

For additional insight take a look at Biocartis page and contact our Product Managers for additional information nova@novabio.ee, nova@novabio.lt 

Your NOVA